Immuneering appoints Dr. Thomas Schall to Compensation Committee effective Oct 1, 2024

Immuneering Corp

Dr. Thomas Schall appointed to Compensation Committee of Board, effective Oct 1, 2024.
Previous election as Class I director on March 11, 2024; committee assignment now settled.
Appointment follows recommendation of Nominating and Corporate Governance Committee.

item 5.02

Immuneering Corp filing history →

Source: SEC EDGAR

accession 0001790340-24-000073

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.